American Century Companies’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
JT
SCM
VA
SSC
JHC
O
American Century Companies's RLMD Position: Q2 2026 in Review
American Century Companies opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 67,348 shares worth $466K. The stake represents ﹤0.01% of the portfolio and ranks #2599 among its holdings. This is a return to the name: American Century Companies previously reported a position in RLMD as recently as Q3 2024.
American Century Companies first reported a position in RLMD in Q1 2024 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.
- American Century Companies held 67,348 shares of Relmada Therapeutics worth $466K as of Q2 2026.
- Relmada Therapeutics was a new American Century Companies position in Q2 2026.
- Relmada Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2599 holding.
- American Century Companies first reported a position in Relmada Therapeutics in Q1 2024 and has held it in 4 quarters since.
- 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.